Sharada Katkuri

1.2k total citations
7 papers, 1.0k citations indexed

About

Sharada Katkuri is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Sharada Katkuri has authored 7 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Pharmacology and 4 papers in Oncology. Recurrent topics in Sharada Katkuri's work include Inflammatory mediators and NSAID effects (6 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and Cancer, Lipids, and Metabolism (2 papers). Sharada Katkuri is often cited by papers focused on Inflammatory mediators and NSAID effects (6 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and Cancer, Lipids, and Metabolism (2 papers). Sharada Katkuri collaborates with scholars based in United States, Switzerland and Japan. Sharada Katkuri's co-authors include Raymond N. DuBois, Dingzhi Wang, Sudhansu K. Dey, Haibin Wang, Béatrice Desvergne, F. Gregory Buchanan, Haibin Wang, Rajnish A. Gupta, Vijaykumar Holla and Jason R. Mann and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Sharada Katkuri

7 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sharada Katkuri United States	7	592	490	364	212	185	7	1.0k
Russell D. Klein United States	20	524 0.9×	305 0.6×	246 0.7×	229 1.1×	290 1.6×	24	1.1k
Sung Hyeok Hong United States	10	324 0.5×	218 0.4×	174 0.5×	272 1.3×	131 0.7×	17	860
N S Paranka United States	8	334 0.6×	766 1.6×	211 0.6×	253 1.2×	425 2.3×	10	1.1k
P.‐J. Jakobsson Sweden	8	189 0.3×	401 0.8×	150 0.4×	111 0.5×	222 1.2×	17	665
D A Edwards United States	2	266 0.4×	741 1.5×	206 0.6×	227 1.1×	452 2.4×	2	1.1k
Sambasiva M. Rao United States	20	733 1.2×	154 0.3×	189 0.5×	317 1.5×	175 0.9×	26	1.4k
A. Terrece Pearman United States	7	509 0.9×	172 0.4×	171 0.5×	226 1.1×	120 0.6×	8	802
Anna Sivula Finland	8	370 0.6×	753 1.5×	267 0.7×	278 1.3×	508 2.7×	9	1.3k
Paola Gerletti United States	6	190 0.3×	467 1.0×	172 0.5×	335 1.6×	152 0.8×	9	915
Keng-Mean Lin United States	6	397 0.7×	197 0.4×	199 0.5×	114 0.5×	99 0.5×	7	718

Countries citing papers authored by Sharada Katkuri

Since Specialization

Citations

This map shows the geographic impact of Sharada Katkuri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharada Katkuri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharada Katkuri more than expected).

Fields of papers citing papers by Sharada Katkuri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharada Katkuri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharada Katkuri. The network helps show where Sharada Katkuri may publish in the future.

Co-authorship network of co-authors of Sharada Katkuri

This figure shows the co-authorship network connecting the top 25 collaborators of Sharada Katkuri. A scholar is included among the top collaborators of Sharada Katkuri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharada Katkuri. Sharada Katkuri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Buchanan, F. Gregory, et al.. (2007). Targeting Cyclooxygenase-2 and the Epidermal Growth Factor Receptor for the Prevention and Treatment of Intestinal Cancer. Cancer Research. 67(19). 9380–9388. 66 indexed citations

2.

Wang, Dingzhi, Haibin Wang, Ning Wei, et al.. (2006). Crosstalk between peroxisome proliferator-activated receptor δ and VEGF stimulates cancer progression. Proceedings of the National Academy of Sciences. 103(50). 19069–19074. 154 indexed citations

3.

Buchanan, F. Gregory, et al.. (2005). Oncogenic Potential of MEK1 in Rat Intestinal Epithelial Cells Is Mediated via Cyclooxygenase-2. Gastroenterology. 129(2). 577–590. 23 indexed citations

4.

Wang, Dingzhi, Haibin Wang, Qiong Shi, et al.. (2004). Prostaglandin E2 promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor δ. Cancer Cell. 6(3). 285–295. 278 indexed citations

5.

Gupta, Rajnish A., Dingzhi Wang, Sharada Katkuri, et al.. (2004). Activation of nuclear hormone receptor peroxisome proliferator–activated receptor-δ accelerates intestinal adenoma growth. Nature Medicine. 10(3). 245–247. 234 indexed citations

6.

Backlund, Michael G., Jason R. Mann, Vijaykumar Holla, et al.. (2004). 15-Hydroxyprostaglandin Dehydrogenase Is Down-regulated in Colorectal Cancer. Journal of Biological Chemistry. 280(5). 3217–3223. 240 indexed citations

7.

Holla, Vijaykumar, Dingzhi Wang, Joanne R. Brown, et al.. (2004). Prostaglandin E2 Regulates the Complement Inhibitor CD55/Decay-accelerating Factor in Colorectal Cancer. Journal of Biological Chemistry. 280(1). 476–483. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact